Reduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications

Epilepsia

Volumn 46, Issue 2, 2005, Pages 236-243

  Bookheimer, Susan ^a   Schrader, Lara M ^a   Rausch, Rebecca ^a   Sankar, Raman ^a   Engel Jr , Jerome ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbonic anhydrase inhibition; Intracarotid amobarbital procedure (IAP); Topiramate; Wada test

Indexed keywords

AMOBARBITAL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; TOPIRAMATE; ZONISAMIDE;

ADULT; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; CONTROLLED STUDY; DEMOGRAPHY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC FOCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEMORY; PRIORITY JOURNAL; REVIEW; WADA TEST;

AMOBARBITAL; ANESTHESIA; ANTERIOR TEMPORAL LOBECTOMY; ANTICONVULSANTS; CARBONIC ANHYDRASE INHIBITORS; CAROTID ARTERY, INTERNAL; CEREBRAL CORTEX; DRUG INTERACTIONS; EPILEPSY; FUNCTIONAL LATERALITY; HUMANS; INJECTIONS, INTRA-ARTERIAL; MEMORY; MEMORY DISORDERS; PREOPERATIVE CARE; SPEECH;

EID: 13244284545     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2005.23904.x     Document Type: Review

References (32)

1. Wada J, Rasmussen T. Intracarotid injection of sodium amytal for the lateralization of speech dominance. Neurosurgery 1960;17:266-82.
2. Milner BR. Study of short term memory after intracarotid injection of sodium amytal. Trans Am Neurol Assoc 1962;87:224-6.
3. Blume WT, Grabow JD, Darley FL, Avonson AE, et al. Intracarotid amobarbital test of language and memory before temporal lobectomy for seizure control. Neurology 1973;23:812-9.
4. Rausch R. Role of the neuropsychological evaluation and the intracarotid sodium amobarbital procedure in the surgical treatment for epilepsy. Epilepsy Res Suppl 1992;5:77-86.
5. Jones-Gotman M. Intra-arterial amobarbital procedure. In: Engel TA, ed. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven, 1997:1767-75.
6. Meador KJ, Loring DW. The Wada test: controversies, concerns, and insights. Neurology 1999;52:1535-6.
7. Jones-Gotman MI, Rouleau I, Snyder PJ. Clinical and research contributions of the intracarotid amobarbital procedure to neuropsychology. Brain Cogn 1997;33:1-6.
8. Rausch R, Le M-T, Langfitt JT. Intra-carotid amobarbital procedure. In: Engel JJ, ed. Surgical Treatment of the Epilepsies. New York, Raven Press, 1993.
9. Snyder PJ, Novelly RA, Harris RJ. Mixed speech dominance in the intracarotid sodium amytal procedure: validity and criteria issues. J Clin Exp Neuropsychol 1990;12:629-43.
10. Rausch R, Reisinger M. Intracarotid sodium amobarbital procedure. In: Boulton AH, Baker G, Hiscock M, eds. Neuromethods: Neuropsychology. Clifton, NJ: Humana Press. 1997:127-40.
11. McCabe PH, Eslinger PJ. Abnormal Wada and neuropsychological testing results due to topiramate therapy. Epilepsia 2000;41:906-8.
12. Moshe SL. Mechanisms of action of anticonvulsant agents. Neurology 2000;55(suppl 1):S32-40; discussion S54-8.
13. Masuda Y, Karasawa T. Inhibitory effect of zonisamide on human carbonic anhydrase in vitro. Arzneimittelforschung 1993;43:416-8.
14. Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug action. Epilepsia 1999;40;1471-83.
15. Sankar R, Holmes GL. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol 2004;19(suppl 1):S6-14.
16. Svensson AI, Berntsson A, Eirefelt M, Soderpalm B. Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes. J Neural Transm 2000;107:261-70.
17. Staley KJ. Diuretics as antiepileptic drugs: should we go with the flow? Epilepsy Currents 2002;2:35-8.
18. Takeoka M, Holmes GL, Thiele E, et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 2001;42:387-92.
19. Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia 2004;59:830.
20. A receptors: dependence on neuronal development. J Physiol 2001;530(Pt 2):219-33.
21. Rivera C, Wegelius K, Reeben M, et al. Different sensitivities of human and rat rho(1) GABA receptors to extracellular pH. Neuropharmacology 2000;39:977-89.
22. Krishek BJ, Amato A, Connolly CN, et al. Proton sensitivity of the GABA(A) receptor is associated with the receptor subunit composition. J Physiol 1996;492(Pt 2):431-43.
23. Thompson PJ, Baxendale SA, Duncan JS, Sander JW, et al. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69:636-41.
24. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-7.
25. Meador KJ, Loring DW, Hulihan JF, et al. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003;60:1483-8.
26. Rorsman I, Kallen K. Recovery of cognitive and emotional functioning following withdrawal of topiramate maintenance therapy. Seizure 2001;10:592-5.
27. Mula M, Trimble MR, Thompson P, Sander JW. Topiramate and word-finding difficulties in patients with epilepsy. Neurology 2003;60:1104-7.
28. Mula M, Trimble MR, Sander JW. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 2003;44:1573-7.
29. Ojemann LM, Ojemann GA, Dodvill CB, et al. Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behav 2001;2:579-84.
30. Kipervasser S, Andelman F, Kramer U, et al. Effects of topiramate on memory performance on the intracarotid amobarbital (Wada) test. Epilepsy Behav 2004;5:197-203.
31. Bouwer MS, Jones-Gotman M, Gotman J. Duration of sodium amytal effect: behavioral and EEG measures. Epilepsia 1993;34:61-8.
32. Rausch R, Fedio P, Ary CM, et al. Resumption of behavior following intracarotid sodium amobarbital injection. Ann Neurol 1984;15:31-5.